|
NETO2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.63966667705063E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23450147274207E-11 |
| Normal-vs-Stage2 |
8.411600E-01 |
| Normal-vs-Stage3 |
2.09079999979878E-08 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.543500E-03 |
| Stage1-vs-Stage3 |
3.410000E-01 |
| Stage1-vs-Stage4 |
3.35439999998854E-06 |
| Stage2-vs-Stage3 |
5.820600E-04 |
| Stage2-vs-Stage4 |
2.58669999997352E-06 |
| Stage3-vs-Stage4 |
5.076400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.05755420981768E-12 |
| Normal-vs-AfricanAmerican |
2.116600E-03 |
| Normal-vs-Asian |
2.98605584703182E-12 |
| Caucasian-vs-AfricanAmerican |
9.703400E-01 |
| Caucasian-vs-Asian |
1.159610E-01 |
| AfricanAmerican-vs-Asian |
4.463000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.44439999972113E-07 |
| Normal-vs-Female |
7.02315983147628E-12 |
| Male-vs-Female |
6.056800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.94233518158171E-12 |
| Normal-vs-Age(41-60Yrs) |
2.19849694005347E-11 |
| Normal-vs-Age(61-80Yrs) |
7.796200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.065000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.214800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.040500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.055400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.119000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.818200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.654010E-01 |
| Classical-VS-Follicular |
2.13549999905638E-09 |
| Classical-VS-Other |
2.499400E-01 |
| Classical-VS-Normal |
1.62947433324234E-12 |
| Tall-VS-Follicular |
4.6136000000363E-06 |
| Tall-VS-Other |
1.397160E-01 |
| Tall-VS-Normal |
2.80750000025698E-07 |
| Follicular-VS-Other |
2.792200E-01 |
| Follicular-VS-Normal |
9.301800E-01 |
| Other-VS-Normal |
3.164200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.5568999999922E-05 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.06399999921791E-09 |
|
|
